No change for sildenafil

Scheduling for ED treatment to remain prescription only despite pharmacist support for change Leading erectile dysfunction treatment sildenafil will remain as a Schedule 4 (prescription only) treatment after a down scheduling proposal was again rejected by the Therapeutic Goods Administration (TGA), following the rejection of 3 similar proposals since 2017. The latest proposal was to